Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Suven Pharmaceuticals Limited

SUVENPHAR
Current price
1 061.95 INR -45.14 INR (-4.07%)
Last closed 1 099.55 INR
ISIN INE03QK01018
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 282 023 373 129 INR
Yield for 12 month +46.56 %
1Y
3Y
5Y
10Y
15Y
SUVENPHAR
21.11.2021 - 28.11.2021

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited. Address: Galaxy Towers, Hyderabad, India, 500081

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

123 690.47 INR

P/E ratio

114.53

Dividend Yield

Current Year

+10 576 857 216 INR

Last Year

+13 484 012 340 INR

Current Quarter

+2 592 721 787 INR

Last Quarter

+2 320 793 841 INR

Current Year

+6 046 631 214 INR

Last Year

+7 594 528 968 INR

Current Quarter

+2 068 986 326 INR

Last Quarter

+814 777 767 INR

Key Figures SUVENPHAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 209 634 015 INR
Operating Margin TTM 28.84 %
PE Ratio 114.53
Return On Assets TTM 10.50 %
PEG Ratio
Return On Equity TTM 15.86 %
Wall Street Target Price 123 690.47 INR
Revenue TTM 9 401 218 985 INR
Book Value 81.04 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -33.60 %
Dividend Yield
Gross Profit TTM 7 594 528 963 INR
Earnings per share 9.64 INR
Diluted Eps TTM 9.64 INR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -49.60 %
Profit Margin 25.73 %

Dividend Analytics SUVENPHAR

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

1 year

5Y Average Payout Ratio

18.00 %

Dividend History SUVENPHAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 09.09.2022
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 25.09.2020
Dividend Date

Stock Valuation SUVENPHAR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 114.53
Forward PE
Enterprise Value Revenue 29.10
Price Sales TTM 30.01
Enterprise Value EBITDA 71.11
Price Book MRQ 14.18

Financials SUVENPHAR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SUVENPHAR

For 52 weeks

588.72 INR 1 368.19 INR
50 Day MA 1 260.12 INR
Shares Short Prior Month
200 Day MA 971.95 INR
Short Ratio
Shares Short
Short Percent